Scientific letters

• SINUS XL self-expanding stents for pre-stenting in pulmonary valve replacement

  Lisa Bianco, Gerard Marti Aguasca, Yassin Belahnech, Pedro Betrián Blasco

  Rev Esp Cardiol. 2024;77:788-90

• Implications of atrial cardiomyopathy in the incidence of cardioembolic events in patients with cryptogenic stroke

  Marine Vial, Virginie Hean, Antoine Da Costa, Jean-Philippe Camdessanché, Pierre Garnier, Jean-Baptiste Guichard

  Rev Esp Cardiol. 2024;77:790-3

• Use of new pulmonary vasodilators in patients with systemic-pulmonary shunts: a “treat-and-repair” approach

  Manuel Gómez-Bueno, Laura Pérez Gómez, Francisco José Hernández Pérez, Cristina Daniela Mitroi, Mercedes Rivas Lasarte, Javier Segovia Cubero

  Rev Esp Cardiol. 2024;77:793-6

• The state of cardiac rehabilitation in Spain. Results of the AULARC registry

  Vicente Arrarte Esteban, Raquel Campuzano Ruiz, Carmen De Pablo Zarzosa, M. Rosa Fernández Olmo, on behalf of the investigators of the AULARC registry

  Rev Esp Cardiol. 2024;77:796-8

• Dilated cardiomyopathy associated with cardiotoxicity due to consumption of energy drinks

  Néstor Báez-Ferrer, Patricia Corina Parra-Esquivel, Carmen Montserrat Rodríguez-Cabrera, Guillermo Burillo-Putze, Pablo Avanzas, Alberto Domínguez-Rodríguez

  Rev Esp Cardiol. 2024;77:699-700

• Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?

  María Anguita-Gámez, David Vivas, Raquel Ferrandis, María Asunción Esteve-Pastor, Francisco Marín, Manuel Anguita Sánchez, On behalf of the REQXAA study investigators

  Rev Esp Cardiol. 2024;77:701-3

• Response to levosimendan predicts response to cardiac contractility modulation therapy: a pilot study

  Daniele Masarone, Luigi Falco, Antonio d’Onofrio, Gerardo Nigro, Ernesto Ammendola, Giuseppe Pacileo

  Rev Esp Cardiol. 2024;77:703-5

• Gore atrial septal occluder devices as an option in patients with nickel allergy

  Eduardo Flores-Umanzor, Mark Osten, Joel DeKoven, Lee Benson, Lusine Abrahamyan, Eric Horlick

  Rev Esp Cardiol. 2024;77:697-9

• Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction

  Miguel A. Pérez-Velasco, Alicia Trenas, M. Rosa Bernal-López, María D. García de Lucas, Ricardo Gómez-Huelgas, Luis M. Pérez-Belmonte

  Rev Esp Cardiol. 2024;77:583-7

• Heritable pulmonary arterial hypertension in rats with spontaneous systemic hypertension

  Francisco Javier Roldán Gómez, Alberto Aranda Fraustro, Laura Gómez Soto, Tomás Pulido Zamudio, Alicia Sánchez Mendoza, José A. Barbosa Carreño

  Rev Esp Cardiol. 2024;77:587-8

• Adjusted morbidity groups and geriatric assessment in older patients with acute coronary syndrome

  Albert Ariza-Solé, Francesc Formiga, David Monterde, Emili Vela, Elena Calvo, Josep Comín-Colet

  Rev Esp Cardiol. 2024;77:589-91

• ChatGPT-4 versus human assessment in cardiology peer review

  Agustín Fernández-Cisnal, Pablo Avanzas, David Filgueiras-Rama, Pablo Garcia-Pavia, Laura Sanchis, Juan Sanchis

  Rev Esp Cardiol. 2024;77:591-4

• Expert center and balloon pulmonary angioplasty network program in chronic thromboembolic pulmonary hypertension: safety and effectiveness of a pioneering experience

  Maite Velázquez Martín, Antonio Gómez Menchero, Rocío González Ferreiro, Abel Andrés Morist, Nicolas Maneiro Melón, Pilar Escribano Subias

  Rev Esp Cardiol. 2024;77:490-3

• Usefulness of remote pulmonary arterial pressure monitoring in patients with advanced heart failure listed for HT

  David Couto-Mallón, Daniel Enríquez-Vázquez, Ramón Calviño-Santos, Carlos Velasco-García de Sierra, José Manuel Rodríguez-Vázquez, María G. Crespo-Leiro

  Rev Esp Cardiol. 2024;77:493-5

• Initial experience with a circulatory support program in massive pulmonary thromboembolism

  Raimundo García Del Moral, Juan Caballero-Borrego, Fernando Sabatel-Pérez, José Damián Herrera Mingorance, Álvaro Cabrera Peña, Manuel Colmenero

  Rev Esp Cardiol. 2024;77:495-8

• Results of a population screening program for hereditary transthyretin amyloidosis

  Fernando de Frutos, Isabel Caraballo Ramos, Victoria Martínez Chaves, Adoración María Corral Azor, Mohamed Solimán Berchíd Débdi, Pablo García-Pavía

  Rev Esp Cardiol. 2024;77:498-500

• Safety and efficacy of diflunisal in transthyretin cardiac amyloidosis

  Belén Peiró-Aventín, Eva Cabrera-Romero, Nerea Mora-Ayestarán, Fernando Domínguez, Esther González-López, Pablo García-Pavía

  Rev Esp Cardiol. 2024;77:426-8

• Age-related dynamic embolic risk in patients with nonvalvular atrial fibrillation

  David González-Fernández, Sergio Raposeiras-Roubín, André González-García, Carla Iglesias-Otero, Andrés Íñiguez-Romo, Emad Abu-Assi

  Rev Esp Cardiol. 2024;77:429-30

• C-reactive protein in patients with acute heart failure and preserved ejection fraction

  Sandra Villar, Anna Mollar, Miguel Lorenzo, Gonzalo Núñez, Rafael de la Espriella, Julio Núñez

  Rev Esp Cardiol. 2024;77:430-3

• Assessing the accuracy of ChatGPT as a decision support tool in cardiology

  Carlos Baladrón, Teresa Sevilla, Manuel Carrasco-Moraleja, Itziar Gómez-Salvador, Julio Peral-Oliveira, José Alberto San Román

  Rev Esp Cardiol. 2024;77:433-5